Ashwagandha

Ashwagandha powder

Products
111
NIH LiverTox — hepatotoxicity
Category B · Highly likely cause
About LiverTox →

LiverTox Category B. 2019-2024: rising case reports of idiosyncratic hepatitis. Iceland DHPA 2024 advisory; EU scrutiny ongoing. Heightened risk with existing liver disease or concurrent hepatotoxic drugs.

LiverTox record (NIH NCBI Bookshelf) →
Label dose distribution · 111 labeled products
Min
120 mcg
Typical
705.443 mg
Max
3 g
Other forms of Ashwagandha

25 sibling forms

Distinct chemical forms sharing the same parent nutrient. Different UNIIs, different bioavailability, different effects — never collapsed.

Products with avoid-level excipients
10

contain Ashwagandha powder AND at least one authority-avoid-flagged excipient

Products with caution-level excipients
3

contain Ashwagandha powder alongside a caution-flagged filler

Top brands carrying Ashwagandha powder

15 brands rolled up

Products containing Ashwagandha powder

111 in catalog